Table 2.
Safety data at 6 months of follow-up.
| LD group n = 16 |
MD group n = 16 |
HD group n = 8 |
|
|---|---|---|---|
| Injection-related AE | |||
| Synovitis, n (%) | 0 | 1 (6,2) | 3 (37.5) |
| Clinically significant pain*, n (%) | 6 (37,5) | 11 (68,7) | 8 (100) |
| Infection, n (%) | 0 | 0 | 0 |
| Fever, n (%) | 1 (6,2) | 0 | 0 |
Data are presented as n.
Abbreviation: AE, adverse events.